Aducanumab approval highlights value of brain disease biomarkers statnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from statnews.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
NEW YORK, May 20, 2021 /PRNewswire/ The Michael J. Fox Foundation for Parkinson s Research (MJFF) today announced that Deborah W. Brooks has been named CEO and Co-Founder of the nation s leading organization dedicated to finding a cure for Parkinson s disease (PD). She takes the helm at a critical moment as the Foundation seeks to accelerate its mission by complementing its aggressively funded research agenda with efforts to engage the nationwide and international patient, family and researcher community in the development of improved therapies for those living with Parkinson s today. Having co-founded MJFF with Michael J. Fox in 2000 and served as CEO until 2007 and Executive Vice Chairman until the present day, Brooks is a central architect of the Foundation s milestone-driven, innovative research model that has generated more than $1 billion to support Parkinson s research.
Leeds, UK, April 19, 2021 - 4D pharma plc (AIM: DDDD; NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) - a novel class of drug derived from the microbiome, today announces a collaboration with Parkinson s UK, a non-profit organization focused on advancing the understanding of Parkinson s disease and improving treatments, to establish a Patient Advisory Board.
The Patient Advisory Board (PAB) will be comprised of people living with Parkinson s. Supported by Parkinson s UK, the PAB will provide valuable patient-centric perspective to 4D pharma as it continues to advance novel Live Biotherapeutics into the clinic to treat neurodegenerative conditions such as Parkinson s. The PAB will also focus on raising awareness of the issues people with Parkinson s face with current treatment options.
4D pharma collaborates with Parkinson s UK to establish Patient Advisory Board pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Is a loss of smell an early sign of Parkinson’s?
The symptom has been in the spotlight because of Covid but, as was the case for Barrie Smith, it could indicate something else entirely
10 April 2021 • 5:00pm
Barrie Smith lost his sense of smell at 29 and was diagnosed with Parkinson’s 18 years later
Credit: Andrew Fox/The Telegraph
Barrie Smith was 29 when his sense of smell suddenly disappeared almost overnight. “I kept smelling something like electrical burning, which was really weird,” he remembers. “And then within about two weeks, I couldn’t smell a thing.”
Smith assumed it was only a temporary problem. But his ability to smell never returned, and over the following 15 years, a constellation of new ailments kept emerging, from bouts of insomnia, to digestive issues, high blood pressure, and an episode of depression.